- Home
- PNR vs RVTY Comparison
PNR vs RVTY Comparison
Compare PNR & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PNR | RVTY |
|---|---|---|
| Founded | 1966 | 1937 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.1B | 11.6B |
| IPO Year | 2003 | 1994 |
Fundamental Metrics
Financial Performance| Metric | PNR | RVTY |
|---|---|---|
| Price | $65.61 | $113.62 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 16 | 16 |
| Target Price | ★ $109.73 | $109.67 |
| AVG Volume (30 Days) | ★ 3.3M | 1.2M |
| Earning Date | 04-28-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.34% | 0.34% |
| EPS Growth | ★ 5.88 | N/A |
| EPS | ★ 1.05 | 0.36 |
| Revenue | N/A | ★ $3,311,822,000.00 |
| Revenue This Year | $4.24 | $6.37 |
| Revenue Next Year | $4.82 | $5.10 |
| P/E Ratio | ★ $63.42 | $314.68 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $57.60 | $81.22 |
| 52 Week High | $113.95 | $118.30 |
Technical Indicators
Market Signals| Indicator | PNR | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 43.91 | 57.91 |
| Support Level | $57.60 | $95.31 |
| Resistance Level | $77.03 | $117.23 |
| Average True Range (ATR) | 2.79 | 3.56 |
| MACD | -0.09 | -0.35 |
| Stochastic Oscillator | 44.16 | 80.09 |
Price Performance
Historical ComparisonAbout PNR Pentair plc.
Pentair is a global leader in the water treatment industry, with 10,000 employees and a presence in 25 countries. Its business is organized into three segments: pool, water technologies, and flow. The company offers a wide range of water solutions, including energy-efficient swimming pool equipment, filtration solutions, and commercial and industrial pumps. Pentair generated approximately $4.2 billion in revenue in 2025.
About RVTY Revvity Inc.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.